Abstract
The association of opportunistic infections in the context of anti-tumor necrosis factor (TNF) antibody therapies have attracted widespread attention. The recent H1N1 influenza pandemic brought this into sharp focus with numerous patient queries and physician anxieties. The following short review gives a scientific perspective to this issue including the role of vaccination.
| Original language | English |
|---|---|
| Pages (from-to) | 173-177 |
| Number of pages | 5 |
| Journal | Therapeutic Advances in Gastroenterology |
| Volume | 3 |
| Issue number | 3 |
| DOIs | |
| Publication status | Published - May 2010 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Anti-tumor necrosis factor antibody
- Inflammatory bowel disease
- Influenza
- Vaccine
Fingerprint
Dive into the research topics of 'Anti-tumor necrosis factor therapy and influenza: Keeping it in perspective'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver